Clara L. Cuevas-Santos

Ocoyoacac, MEX 52750, Mexico

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications

Machine learning-based analysis of average glandular dose in mammography: The role of breast density.

Machine learning-based analysis of average glandular dose in mammography: The role of breast density.

Journal: Radiography (London, England : 1995)
Published: April 22, 2026

Synthesis and Evaluation of [18F]AlF-NOTA-iPD-L1 as a Potential Theranostic Pair for [177Lu]Lu-DOTA-iPD-L1.

Synthesis and Evaluation of [18F]AlF-NOTA-iPD-L1 as a Potential Theranostic Pair for [177Lu]Lu-DOTA-iPD-L1.

Journal: Pharmaceutics
Published: May 30, 2025

Lutetium-177 labeled iPD-L1 as a novel immunomodulator for cancer-targeted radiotherapy.

Lutetium-177 labeled iPD-L1 as a novel immunomodulator for cancer-targeted radiotherapy.

Journal: EJNMMI radiopharmacy and chemistry
Published: December 02, 2024

An evaluation of the current status of quality assurance program in MRI: A multicenter study.

An evaluation of the current status of quality assurance program in MRI: A multicenter study.

Journal: Radiography (London, England : 1995)
Published: November 21, 2024

Establishing mammography diagnostic reference levels in Mexico: A step towards improving patient radiation protection.

Establishing mammography diagnostic reference levels in Mexico: A step towards improving patient radiation protection.

Journal: Radiography (London, England : 1995)
Published: October 10, 2024

Theranostic Potential of the iPSMA-Bombesin Radioligand in Patients with Metastatic Prostate Cancer: A Pilot Study.

Theranostic Potential of the iPSMA-Bombesin Radioligand in Patients with Metastatic Prostate Cancer: A Pilot Study.

Journal: Pharmaceutics
Published: September 21, 2024

The cytotoxic effect of quercetin-induced apoptosis on lung metastatic cells from giant cell tumor of bone.

The cytotoxic effect of quercetin-induced apoptosis on lung metastatic cells from giant cell tumor of bone.

Journal: Cellular and molecular biology (Noisy-le-Grand, France)
Published: February 14, 2024

68Ga-DOTA-D-Alanine-BoroPro Radiotracer for Imaging of the Fibroblast Activation Protein in Malignant and Non-Malignant Diseases.

68Ga-DOTA-D-Alanine-BoroPro Radiotracer for Imaging of the Fibroblast Activation Protein in Malignant and Non-Malignant Diseases.

Journal: Pharmaceutics
Published: January 09, 2024

225Ac-iPSMA-RGD for Alpha-Therapy Dual Targeting of Stromal/Tumor Cell PSMA and Integrins.

225Ac-iPSMA-RGD for Alpha-Therapy Dual Targeting of Stromal/Tumor Cell PSMA and Integrins.

Journal: International journal of molecular sciences
Published: October 16, 2023

99mTc-Labeled Cyclic Peptide Targeting PD-L1 as a Novel Nuclear Imaging Probe.

99mTc-Labeled Cyclic Peptide Targeting PD-L1 as a Novel Nuclear Imaging Probe.

Journal: Pharmaceutics
Published: October 15, 2023

Synthesis and Evaluation of 177Lu-DOTA-PD-L1-i and 225Ac-HEHA-PD-L1-i as Potential Radiopharmaceuticals for Tumor Microenvironment-Targeted Radiotherapy.

Synthesis and Evaluation of 177Lu-DOTA-PD-L1-i and 225Ac-HEHA-PD-L1-i as Potential Radiopharmaceuticals for Tumor Microenvironment-Targeted Radiotherapy.

Journal: International journal of molecular sciences
Published: June 30, 2023

Improving Overall Survival and Quality of Life in Patients with Prostate Cancer and Neuroendocrine Tumors Using 177Lu-iPSMA and 177Lu-DOTATOC: Experience after 905 Treatment Doses.

Improving Overall Survival and Quality of Life in Patients with Prostate Cancer and Neuroendocrine Tumors Using 177Lu-iPSMA and 177Lu-DOTATOC: Experience after 905 Treatment Doses.

Journal: Pharmaceutics
Published: June 06, 2023
Showing 1-12 of 60

Last Updated: 09/26/2026